324 related articles for article (PubMed ID: 18520113)
1. Fenofibrate-induced acute renal failure due to massive rhabdomyolysis after coadministration of statin in two patients.
Unal A; Torun E; Sipahioglu MH; Tokgoz B; Kaya MG; Oymak O; Utas C
Intern Med; 2008; 47(11):1017-9. PubMed ID: 18520113
[TBL] [Abstract][Full Text] [Related]
2. A case of rhabdomyolysis induced acute renal failure secondary to statin-fibrate-derivative combination and occult hypothyroidism.
Kursat S; Alici T; Colak HB
Clin Nephrol; 2005 Nov; 64(5):391-3. PubMed ID: 16312269
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations.
Oldemeyer JB; Lund RJ; Koch M; Meares AJ; Dunlay R
Cardiology; 2000; 94(2):127-8. PubMed ID: 11173785
[TBL] [Abstract][Full Text] [Related]
4. Incidence of hospitalized rhabdomyolysis with statin and fibrate use in an insured US population.
Amend KL; Landon J; Thyagarajan V; Niemcryk S; McAfee A
Ann Pharmacother; 2011 Oct; 45(10):1230-9. PubMed ID: 21917557
[TBL] [Abstract][Full Text] [Related]
5. [Rhabdomyolysis secondary to simvastatin and phenofibrate].
Forcadell-Peris MJ; de Diego-Cabanes C
Semergen; 2014; 40(4):e91-4. PubMed ID: 24768027
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of safety of the coadministration of statin with fenofibrate in patients with combined hyperlipidemia.
Guo J; Meng F; Ma N; Li C; Ding Z; Wang H; Hou R; Qin Y
Am J Cardiol; 2012 Nov; 110(9):1296-301. PubMed ID: 22840347
[TBL] [Abstract][Full Text] [Related]
7. A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: a first report.
Kiskac M; Zorlu M; Cakirca M; Karatoprak C; Peru C; Erkoc R; Yavuz E
Indian J Pharmacol; 2013; 45(3):305-6. PubMed ID: 23833382
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of fenofibrate as an add-on in patients with elevated triglyceride despite receiving statin treatment.
Zhao S; Wang F; Dai Y; Lin L; Tong Q; Liao Y; Yin Y; Wang G; Yan Y; Li X; Wang D; Wei P; Cheng X; Xie Q; Sun Y; Fu G; Huang H; Dong Y; Liu J; Yan J; Yan L; Cui S; Liu X; Li Z; Chen H; Hu T; Gong H
Int J Cardiol; 2016 Oct; 221():832-6. PubMed ID: 27434354
[TBL] [Abstract][Full Text] [Related]
9. Statin-fibrate combination therapy.
Shek A; Ferrill MJ
Ann Pharmacother; 2001; 35(7-8):908-17. PubMed ID: 11485144
[TBL] [Abstract][Full Text] [Related]
10. Statin-associated rhabdomyolysis with acute renal failure complicated by intradialytic NSTEMI: a review of lipid management considerations.
Kar S; Chockalingam A
Am J Ther; 2013 Jan; 20(1):57-60. PubMed ID: 21192242
[TBL] [Abstract][Full Text] [Related]
11. Rhabdomyolysis with cardiac involvement and acute renal failure in a patient taking rosuvastatin and fenofibrate.
Ireland JH; Eggert CH; Arendt CJ; Williams AW
Ann Intern Med; 2005 Jun; 142(11):949-50. PubMed ID: 15941707
[No Abstract] [Full Text] [Related]
12. Fenofibrate-induced rhabdomyolysis in a patient with chronic renal failure due to nephrotic syndrome: a rare case report.
Erdur FM; Soyoral YU; Emre H; Begenik H; Canbaz ET; Erkoc R
Clin Biochem; 2012 Jan; 45(1-2):162-4. PubMed ID: 22019952
[TBL] [Abstract][Full Text] [Related]
13. Fenofibrate-induced rhabdomyolysis in a patient with stage 4 chronic renal failure due to diabetes mellitus.
Soyoral YU; Canbaz ET; Erdur MF; Emre H; Begenik H; Erkoc R
J Pak Med Assoc; 2012 Aug; 62(8):849-51. PubMed ID: 23862266
[TBL] [Abstract][Full Text] [Related]
14. Acute renal failure due to fenofibrate monotherapy.
Usküdar Cansu D; Yaşar NS; Korkmaz C
Anadolu Kardiyol Derg; 2011 Jun; 11(4):371-2. PubMed ID: 21592934
[No Abstract] [Full Text] [Related]
15. Adverse events following statin-fenofibrate therapy versus statin alone: a meta-analysis of randomized controlled trials.
Geng Q; Ren J; Chen H; Lee C; Liang W
Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):219-26. PubMed ID: 23324122
[TBL] [Abstract][Full Text] [Related]
16. Rhabdomyolysis in a Prostate Cancer Patient Taking Ketoconazole and Simvastatin: Case Report and Review of the Literature.
Watkins JL; Atkinson BJ; Pagliaro LC
Ann Pharmacother; 2011 Feb; 45(2):e9. PubMed ID: 21304039
[TBL] [Abstract][Full Text] [Related]
17. [Rhabdomyolysis induced by fenofibrate monotherapy].
Archambeaud-Mouveroux F; Lopez S; Combes C; Lassandre S; Amaniou M; Teissier MP; Galinat S
Rev Med Interne; 2006 Jul; 27(7):573-4. PubMed ID: 16716459
[TBL] [Abstract][Full Text] [Related]
18. Safety of a fixed-dose combination of fenofibrate/pravastatin 160 mg/40 mg in patients with mixed hyperlipidaemia: a pooled analysis from a database of clinical trials.
Farnier M; Marcereuil D; De Niet S; Ducobu J; Steinmetz A; Retterstøl K; Bryniarski L; Császár A; Vanderbist F
Clin Drug Investig; 2012 Apr; 32(4):281-91. PubMed ID: 22350498
[TBL] [Abstract][Full Text] [Related]
19. Influenza vaccine--a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate.
Plotkin E; Bernheim J; Ben-Chetrit S; Mor A; Korzets Z
Nephrol Dial Transplant; 2000 May; 15(5):740-1. PubMed ID: 10809833
[No Abstract] [Full Text] [Related]
20. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
Chang JT; Staffa JA; Parks M; Green L
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
